Skip to main content
Signal8

Aromando Andrew

SEC insider (Form 3/4/5 filer). CIK 0001976455. Chief Business Officer at ONCOLYTICS BIOTECH INC (ONCY). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in SAN DIEGO, CA.

Companies Aromando Andrew has filed insider reports for

  • ONCOLYTICS BIOTECH INC (ONCY): Officer, Chief Business Officer
Aromando Andrew profile photo

Aromando Andrew

CIK: 0001976455

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ONCOLYTICS BIOTECH INC logo
ONCY

ONCOLYTICS BIOTECH INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Jun 1, 2026
    Award

    Stock Option

    Direct
    260K shares-
  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Feb 11, 2026
    Purchase
    Direct
    29.6K shares at avg. $0.86$25K

1-2 of 2